Maiden Holdings, Ltd. Underwriting AgreementUnderwriting Agreement • October 1st, 2013 • Maiden Holdings, Ltd. • Fire, marine & casualty insurance • New York
Contract Type FiledOctober 1st, 2013 Company Industry JurisdictionMaiden Holdings, Ltd., an exempted company incorporated in Bermuda (the "Company"), proposes, subject to the terms and conditions stated herein, to issue and sell to the several Underwriters named in Schedule I hereto (collectively, the "Underwriters", which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Goldman, Sachs & Co., Morgan Stanley & Co. LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated are acting as representatives (the “Representatives”), 3,000,000 shares (the "Firm Shares") and, at the election of the Underwriters, up to 300,000 additional shares (the "Optional Shares") of its 7.25% Mandatory Convertible Preference Shares, Series B, with an initial liquidation preference of $50 per share (the "Preference Shares"). The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are collectively referred to herein as the "Shares." The terms of the Preference Shar
26,700,000 Shares National Penn Bancshares, Inc. Common Stock no stated par value Underwriting AgreementUnderwriting Agreement • September 15th, 2009 • National Penn Bancshares Inc • National commercial banks • New York
Contract Type FiledSeptember 15th, 2009 Company Industry JurisdictionNational Penn Bancshares, Inc., a Pennsylvania corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Sandler O’Neill & Partners, L.P. (“Sandler O’Neill” or an “Underwriter”) and each of the other underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 11 hereof), for whom Sandler O’Neill is acting as representative (in such capacity, the “Representative”) with respect to (i) the sale by the Company, and the purchase by the Underwriters, acting severally and not jointly, of an aggregate of 26,700,000 shares of common stock, no stated par value, of the Company (the “Stock”), as set forth in Schedule I hereto (the “Firm Shares”) and (ii) the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 2 hereof to purchase all or any part of 4,005,000 additional shares of co